Question 1

What is the catalog number for Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594]?

Accepted Answer

The catalog number for Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594] is NBP2-70078DL594.

Question 2

What sizes are available for Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594]?

Accepted Answer

Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594] is available in the following size(s): 0.1 mL.

Question 3

Is Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594] in stock?

Accepted Answer

Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Mouse Monoclonal alpha-Actinin 1 Antibody (OTI7A4) [Dylight 594]

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Cytokeratin 18 (KRT18/836), 1mg/mL

Androgen Receptor (AR441), CF647 conjugate, 0.1mg/mL

Anti-Thioredoxin/TRX/Txn Antibody Picoband®

Anti-HELB Antibody Picoband®

Anti-HMGB2 Antibody Picoband® (iFluor647 Conjugate)

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF405S conjugate, 0.1mg/mL